FR Doc 04-19225

[Federal Register: August 23, 2004 (Volume 69, Number 162)]
[Notices]
[Page 51847-51851]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr23au04-50]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

ADAPT: Adopting and Demonstrating the Adaptation of Prevention
Techniques

Announcement Type: Competitive Supplement.
Funding Opportunity Number: PA 04064 (Supplemental).
Catalog of Federal Domestic Assistance Number: 93.944.
Dates: Letter of Intent Deadline: None.
Application Deadline: September 22, 2004.

I. Funding Opportunity Description

Authority: This program is authorized under sections 301 and 317(k)
of the Public Health Service Act, (42 U.S.C. 241 and 247b(k)), as
amended.

Purpose

The purpose of this program is to improve understanding of the
processes needed for adapting evidence-based interventions to fit new
conditions or populations and to pilot CDC-developed draft guidance for
adaptation.
The ADAPT project responds to concerns from the field that existing
interventions do not address the HIV prevention needs of their specific
population. This project seeks to develop guidance for agencies to
engage in evidence-based adaptation of interventions previously shown
to be effective in research settings for use in real world
applications. If data from this project is published, it will be
published as case studies and not as generalizable research data.

Activities

Supplemental funds are intended to support 3-5 eligible grantees
that are currently participating in Community-Based Organizations (CBO)
PA 04064. The funds will support additional activities that involve
adapting an HIV prevention intervention listed in the Procedural
Guidance for Selected Strategies and Interventions for Community-Based
Organizations Funded Under Program Announcement 04064 (Procedural
Guidance) for use in an HIV seropositive population of men of color who
have sex with other men (MSM of color). CDC is especially interested in
supporting projects that use the Many Men, Many Voices (MMMV)
intervention listed in the Procedural Guidance. Contingent upon the
quality of proposals, CDC anticipates that at least one of the
applicants funded under the ADAPT supplement will adapt and implement
MMMV. However, applicants are not limited to this particular
intervention and may propose work using any one of the other
interventions listed in the Procedural Guidance. Funded applicants will
further evaluate the intervention they select to adapt. Preference will
be given to those applicants that have limited or no previous
experience with the adaptation and implementation of the intervention
they were funded to implement under CBO PA 04064. Funded applicants
will be required to conduct two evaluation components for this award:
(1) To monitor and evaluate the adaptation process; and (2) to monitor
and evaluate the intervention.
In a cooperative agreement, CDC staff is substantially involved in
the program activities, above and beyond routine grant monitoring.
CDC Activities for this program are as follows:
CDC will provide to funded applicants the draft adaptation
guidance developed by CDC with input from internal and external
researchers, HIV prevention intervention implementers, and community
advocates.
CDC will provide process and outcome indicators and work
with funded applicants in the evaluation processes for this award. The
evaluation methods could include, but are not limited to: timelines;
qualitative summaries; focus group summaries; unstructured key
informant interviews; case studies; checklists; progress reports; and
perhaps information on costs. Note that evaluation activities will
include unstructured interviews with key stakeholders before and after
the implementation of the adapted intervention(s). Outcome measures
could include, but are not limited to, behavioral outcomes such as
condom use or frequency of unprotected sex, or biological outcomes such
as sexually transmitted disease (STD) incidence as collected with the
Program Evaluation and Monitoring System (PEMS).

II. Award Information

Type of Award: Cooperative Agreement. CDC involvement in this
program is listed in the Activities Section above.
Fiscal Year Funds: 2004--2006.
Approximate Total Funding: The estimated total cost is $5,000,000
with approximately $2,000,000 awarded during the first fiscal year.
Approximate Number of Awards: 3-5.
Approximate Average Award: $575,000 (This amount is for the first
12-month budget period, and includes both direct and indirect costs).
Floor of Award Range: $200,000.
Anticipated Award Date: September 1, 2004.
Budget Period Length: 12 months.
Project Period Length: 2 years.
Throughout the project period, CDC's commitment to continuation of
awards will be conditioned on the availability of funds, evidence of
satisfactory progress by the recipient (as documented in required
reports), and the determination that continued funding is in the best
interest of the Federal Government.

III. Eligibility Information

III.1. Eligible applicants

Applications may only be submitted by grantees currently funded
under CBO PA 04064 who are eligible to apply for supplemental funding.

III.2. Cost Sharing or Matching

Matching funds are not required for this program.

III.3. Other

If your application is incomplete or non-responsive to the
requirements listed in this section, it will not be entered into the
review process. You will be notified that your application did not meet
submission requirements.

[[Page 51848]]

Eligibility Criteria:
Eligibility criteria are briefly outlined below. When writing the
proposal narrative, applicants should refer to the scoring criteria
section for additional details.
a. Only grantees currently funded under CBO PA 04064 are eligible
to apply for supplemental funding.
b. The applicant must demonstrate access to an adequate population
of HIV seropositive MSM of color who are currently not receiving other
prevention interventions. The applicant must demonstrate ability to
obtain a sample size comparable to that found in the original research
study.
c. The applicant must demonstrate adequate personnel for conducting
ADAPT activities in addition to CBO PA 04064 activities. Personnel
assigned to ADAPT activities should include, but are not limited to, an
onsite, full-time person with expertise in development and adaptation
of interventions based on behavioral theory (adaptation specialist) who
works collaboratively with the CBO PA 04064 project coordinator to take
the lead on ADAPT activities; a full-time data manager; a full-time
data entry position; and a part-time administrator.
d. The applicant must demonstrate ability to accomplish ADAPT
activities within a 2-year project period.
e. The applicant must adequately address all sections of the
description of work in the narrative of the proposal.
(1) Approach. The applicant must demonstrate that plans for
adapting, implementing, and monitoring and evaluating the selected
intervention are adequately developed, well-integrated, and appropriate
to the aims of the project.
(2) Significance. The applicant must demonstrate understanding of
the intent and purpose of ADAPT.
(3) Personnel. The applicant must demonstrate adequate personnel
for conducting ADAPT activities in addition to CBO PA 04064 activities
(i.e., adaptation specialist, data manager, data entry, part-time
administrator).
(4) Environment. The applicant should demonstrate how levels of
administrative support, community involvement, facilities, and other
resources at the CBO in which the work will be done contribute to the
probability of success.

Note: Title 2 of the United States Code Section 1611 states that
an organization described in section 501(c)(4) of the Internal
Revenue Code that engages in lobbying activities is not eligible to
receive Federal funds constituting an award, grant, or loan.

IV. Application and Submission Information

IV.1. Address To Request Application Package

To apply for this funding opportunity use application form PHS
5161. Application forms and instructions are available on the CDC web
site, at the following Internet address: http://www.cdc.gov/od/pgo/forminfo.htm
.

If you do not have access to the Internet, or if you have
difficulty accessing the forms on-line, you may contact the CDC
Procurement and Grants Office Technical Information Management Section
(PGO-TIM) staff at: 770-488-2700. Application forms can be mailed to
you.

IV.2. Content and Form of Submission

Application: You must submit a project narrative with your
application forms. The narrative must be submitted in the following
format:
Maximum number of pages: 25 (not including budget
justification and appendices). If your narrative exceeds the page
limit, only the first pages which are within the page limit will be
reviewed.
Font size: 12 point unreduced.
Double spaced.
Paper size: 8.5 by 11 inches.
Page margin size: One inch.
Printed only on one side of page.
Held together only by rubber bands or metal clips; not
bound in any other way.
MS WORD format.
Cover page--the program announcement number and title.
Table of contents--with the major sections and page
numbering including each attachment.
Consecutive page numbering throughout the document,
including the attachments.

[cir] Beginning with the first page of text, number all pages clearly
and sequentially, including each page in the appendices.
[cir] Replace double-sided article reprints with a one-sided copy.

Your narrative should address activities to be conducted over the
entire project period, and must include the following items in the
order listed below.
A. Specific Aims
Applications must include a one-page, double-spaced executive
summary as a cover page.

Maximum number of pages: 1.
Font size: 12-point unreduced.
Double spaced.
Paper size: 8.5 by 11 inches.
Page margin size: One inch.
Printed only on one side of page.
Written in plain language, avoid jargon.

A complete table of contents to the application and its appendices,
and text addressing each required element is required.
B. Background and Significance
An explanation of how the applicant identified, gained
access to, and assessed the prevention needs of the selected target
population.
The rationale for selection of proposed target population
and intervention match.
C. Preliminary Studies/Progress Report
Provide evidence of the applicant's previous experience in
conducting process evaluation, quality assurance, and evaluation.
An outline of personnel roles and responsibilities related
to conducting ADAPT project activities.
The remaining sections of the proposal narrative should correspond
with sections of the scoring criteria. The applicant must adequately
address all relevant items in each section of the scoring criteria.
D. Approach
The applicant must demonstrate that plans for adapting,
implementing, and monitoring and evaluating the selected intervention
are adequately developed, well-integrated, and appropriate to the aims
of the project.
The applicant must submit a copy of their CBO PA 04064 application
packet and award letter.
E. Significance
The applicant must demonstrate understanding of the intent and
purpose of ADAPT.
F. Personnel
The applicant must demonstrate adequate personnel for conducting
ADAPT activities in addition to CBO PA 04064 activities (i.e.,
adaptation specialist, data manager, data entry, part-time
administrator).
G. Environment
The applicant should demonstrate how levels of administrative
support, community involvement, facilities, and other resources at the
CBO in which the work will be done contribute to the probability of
success.

[[Page 51849]]

H. Budget and Justification (Not Included in Page Limit)
I. Additional Information
Additional information may be included in the application
appendices. The appendices will not be counted toward the narrative
page limit. This additional information includes: Curriculum Vitae,
Resumes, Organizational Charts, and Letters of Support. Applications
must include Letters of Support (LOS) from institutions that will play
a role in conducting ADAPT activities. Each LOS should include a
description of the past relationship with the applicant and the role(s)
the local partner will play in conducting ADAPT activities (e.g.,
accessing the target population, implementing the selected
intervention, staff involved). The LOS must be written in the following
format:

You are required to have a Dun and Bradstreet Data Universal
Numbering System (DUNS) number to apply for a grant or cooperative
agreement from the Federal government. The DUNS number is a nine-digit
identification number, which uniquely identifies business entities.
Obtaining a DUNS number is easy and there is no charge. To obtain a
DUNS number, access http://www.dunandbradstreet.com or call 1-866-705-

5711.
For more information, see the CDC Web site at: http://www.cdc.gov/od/pgo/funding/pubcommt.htm
If your application form does not have a

DUNS number field, please write your DUNS number at the top of the
first page of your application, and/or include your DUNS number in your
application cover letter.
Additional requirements that may require you to submit additional
documentation with your application are listed in section ``VI.2.
Administrative and National Policy Requirements.''

IV.3. Submission Dates and Times

Application Deadline Date: September 22, 2004.
Explanation of Deadline: Applications must be received in the CDC
Procurement and Grants Office by 4 p.m. Eastern Time on the deadline
date. If you send your application by the United States Postal Service
or commercial delivery service, you must ensure that the carrier will
be able to guarantee delivery of the application by the closing date
and time. If CDC receives your application after closing due to: (1)
Carrier error, when the carrier accepted the package with a guarantee
for delivery by the closing date and time, or (2) significant weather
delays or natural disasters, you will be given the opportunity to
submit documentation of the carrier's guarantee. If the documentation
verifies a carrier problem, CDC will consider the application as having
been received by the deadline.
This announcement is the definitive guide on application submission
address and deadline. It supersedes information provided in the
application instructions. If your application does not meet the
deadline above, it will not be eligible for review, and will be
discarded. You will be notified that your application did not meet the
submission requirements.
CDC will not notify you upon receipt of your application. If you
have a question about the receipt of your application, first contact
your courier. If you still have a question, contact the PGO-TIM staff
at: 770-488-2700. Before calling, please wait two to three days after
the application deadline. This will allow time for applications to be
processed and logged.

IV.4. Intergovernmental Review of Applications

Executive Order 12372 does not apply to this program.

IV.5. Funding Restrictions

Restrictions, which must be taken into account while writing your
budget, are as follows:
No furniture should be purchased with ADAPT funds.
No rent should be paid for with ADAPT funds unless the
amount is prorated to cover space occupied solely by ADAPT staff.
Travel costs must conform to government rates.
No construction should be paid for with ADAPT funds.
Awards will not allow reimbursement of pre-award costs.
If you are requesting indirect costs in your budget, you must
include a copy of your indirect cost rate agreement. If your indirect
cost rate is a provisional rate, the agreement should be less than 12
months of age.
Guidance for completing your budget can be found on the CDC Web
site, at the following Internet address: http://www.cdc.gov/od/pgo/funding/budgetguide.htm
.

IV.6. Other Submission Requirements

Application Submission Address: Submit the original and two hard
copies of your application by mail or express delivery service to:
Technical Information Management-PA 04064, CDC Procurement and
Grants Office,2920 Brandywine Road, Atlanta, GA 30341.
Applications may not be submitted electronically at this time.

V. Application Review Information

V.1. Criteria

You are required to provide measures of effectiveness that will
demonstrate the accomplishment of the various identified objectives of
the cooperative agreement. Measures of effectiveness must relate to the
performance goals stated in the ``Purpose'' section of this
announcement. Measures must be objective and quantitative, and must
measure the intended outcome. These measures of effectiveness must be
submitted with the application and will be an element of evaluation.
The reviewers will consider each of the following criteria in
assigning the overall score, weighting them as appropriate for each
proposal. Your application will be evaluated against the scoring
criteria as follows:
A. Approach (35 percent)
Has applicant included a brief abstract summarizing their
ADAPT project proposal?
Has the applicant submitted a copy of their CBO PA 04064
application packet and award letter?
Are the plans for adapting, implementing, and monitoring
and evaluating the selected intervention adequately developed, well-
integrated, and appropriate to the aims of the project?
Has the applicant provided strong evidence of experience
with process evaluation, quality assurance, and evaluation with other
related projects?
Has the applicant provided a quality assurance plan (QASP)
that addresses all phases of adaptation, implementation, and monitoring
and evaluation and includes proposed process and outcome measures and
personnel responsible for ensuring quality?
Has the applicant included a timeline including dates that
tasks are to be implemented and completed; costs; development of
materials (e.g., adapted training curriculum, evaluation tools, and
checklists); and quarterly progress report dates?
Does the applicant acknowledge potential problem areas and
consider

[[Page 51850]]

alternative tactics (i.e., recruitment, competing priorities, staffing,
and coordinating ADAPT & CBO PA 04064 activities and PEMS)?
Has the applicant included how they identified, gained
access to, and rapidly assessed the target population (e.g., via
community planning groups [CPGs], community advisory boards [CABs], and
focus groups)?
Has the applicant demonstrated access to an adequate
population of HIV seropositive MSM of color who are currently not
receiving other prevention interventions? Can applicant obtain a sample
size comparable to that found in the original research study of the
chosen intervention?
Is the target population of HIV seropositive MSM of color
population not targeted by the original intervention?
Has the applicant provided a plan for training staff on
the implementation of the adapted intervention?
Has the applicant provided a plan and protocol for timely
adaptation, implementation, and evaluation of the intervention?
Does the applicant's proposed budget for ADAPT activities
include, but is not limited to, personnel (i.e., adaptation specialist,
data manager, data entry, part-time administrator), travel (2 trips to
Atlanta for the adaptation specialist), and supplies?
B. Significance (30 Percent)
Does the applicant demonstrate understanding of the intent
and purpose of ADAPT?
Is the target population HIV seropositive MSM of color?
Is the selection of the target population justified in
terms of risk, service level, and HIV incidence?
Did the applicant provide the rationale for
appropriateness of agency, target population, and intervention match?
Are the agency, target population, and intervention
realistically matched in terms of agency resources and experience,
behavioral determinants, and risk behaviors of the target population,
and maintaining fidelity to the core elements of the intervention?
Did the applicant document adequate capacity to implement
the chosen intervention?
C. Personnel (20 Percent)
Has the applicant demonstrated adequate personnel for
conducting ADAPT activities in addition to CBO PA 04064 activities
(i.e., adaptation specialist, data manager, data entry, part-time
administrator)?
Does the applicant demonstrate adequate capacity and
skills necessary to identify at-risk populations, use local data, and
collaborate with partners (if applicable)?
Is the applicant staff appropriately trained and well
suited to carry out this work?
Is the work proposed appropriate to the experience level
of the applicant staff?
Does the applicant demonstrate previous experience in
managing HIV prevention efforts?
D. Environment (15 percent)
Are the levels of administrative support, community
involvement, facilities, and other resources at the CBO in which the
work will be done sufficient to contribute to a high probability of
success?
Has the applicant demonstrated how they established and
maintain collaboration with local partners, if relevant (e.g., local
health departments, universities, CBOs, ASOs, and research entities)?
Has the applicant demonstrated adequate support for ADAPT
activities (e.g., commitment of resources such as personnel and time;
commitment from management; commitment from community partners).
Has the applicant provided a plan for separate budgeting
of ADAPT and CBO PA 04064 funds?

V.2. Review and Selection Process

Applications will be reviewed for completeness by the Procurement
and Grants Office (PGO) staff, and for responsiveness by National
Center for HIV/AIDS, STD, TB Prevention. Incomplete applications and
applications that are non-responsive to the eligibility criteria will
not advance through the review process. Applicants will be notified
that their application did not meet submission requirements.
An objective review panel will evaluate complete and responsive
applications according to the criteria listed in the ``V.1. Criteria''
section above.
In addition, the following factors may affect the funding decision:

Executive Summary
Letters of Support
Selected Intervention. CDC is especially interested in supporting
projects that use the MMMV intervention listed in the Procedural
Guidance. Contingent upon the quality of proposals, CDC anticipates
that at least one of the applicants funded under the ADAPT supplement
will adapt and implement MMMV. However, applicants are not limited to
this particular intervention and may propose work using any one of the
other interventions listed in the Procedural Guidance.

V.3. Anticipated Announcement and Award Dates

Award date: September 1, 2004.

VI. Award Administration Information

VI.1. Award Notices

Successful applicants will receive a Notice of Grant Award (NGA)
from the CDC Procurement and Grants Office. The NGA shall be the only
binding, authorizing document between the recipient and CDC. The NGA
will be signed by an authorized Grants Management Officer, and mailed
to the recipient fiscal officer identified in the application.
Unsuccessful applicants will receive notification of the results of
the application review by mail.

VI.2. Administrative and National Policy Requirements

45 CFR Part 74 and Part 92
For more information on the Code of Federal Regulations, see the
National Archives and Records Administration at the following Internet
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.

The following additional requirements apply to this project:

AR-4 HIV/AIDS Confidentiality Provisions
AR-5 HIV Program Review Panel Requirements
AR-7 Executive Order 12372
AR-8 Public Health System Reporting Requirements
AR-9 Paperwork Reduction Act Requirements
AR-10 Smoke-Free Workplace Requirements
AR-11 Healthy People 2010
AR-12 Lobbying Restrictions
AR-14 Accounting System Requirements
AR-15 Proof of Non-Profit Status

Additional information on these requirements can be found on the
CDC web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm
.

VI.3. Reporting Requirements

You must provide CDC with an original, plus two hard copies of the
following reports:
1. Interim progress report, no less than 90 days before the end of
the budget period. The progress report will serve as your non-competing
continuation application, and must contain the following elements:
a. Current Budget Period Activities Objectives.

[[Page 51851]]

b. Current Budget Period Financial Progress.
c. New Budget Period Program Proposed Activity Objectives.
d. Budget.
e. Additional Requested Information.
f. Measures of Effectiveness.
2. Financial status report no more than 90 days after the end of
the budget period.
3. Final financial and performance reports, no more than 90 days
after the end of the project period.
These reports must be mailed to the Grants Management or Contract
Specialist listed in the ``Agency Contacts'' section of this
announcement.

VII. Agency Contacts

For general questions about this announcement, contact:

Technical Information Management Section, CDC Procurement and Grants
Office, 2920 Brandywine Road, Atlanta, GA 30341, Telephone: 770-488-
2700.

For program technical assistance, contact:

Vel McKleroy, Extramural Co-Project Officer, Centers for Disease
Control and Prevention, 1600 Clifton Road, Mailstop E-37, Atlanta
Georgia, 30333, Telephone: (404) 639-2982, E-mail: vmckleroy@cdc.gov.
OR
Jennifer Galbraith, Extramural Co-Project Officer, Centers for Disease
Control and Prevention, 1600 Clifton Road, Mailstop E-37, Atlanta
Georgia, 30333, Telephone: (404) 639-8649, E-mail: jgalbraith@cdc.gov.

For financial, grants management, or budget assistance, contact:

Brenda Hayes, Grants Management Specialist, CDC Procurement and Grants
Office, 2920 Brandywine Road, Atlanta, GA 30341, Telephone: 770-488-
2741, E-mail: bkh4@cdc.gov.

Dated: August 17, 2004.
William P. Nichols,
Acting Director, Procurement and Grants Office, Centers for Disease
Control and Prevention.
[FR Doc. 04-19225 Filed 8-20-04; 8:45 am]

BILLING CODE 4163-70-P